IND Strategy & Approval Readiness

IND Strategy & Approval Readiness

Integrated strategy design for IND approval readiness

Service Overview

Service Overview

IND approval is the first critical gateway in drug development and the pivotal stage that determines the success of subsequent clinical development.

LinkedBio designs integrated strategies encompassing non-clinical research, clinical trial planning, and overall development strategy to support high-probability IND submissions and approvals.

IND Strategy & Approval Readiness

IND Submission Flow

IND Approval Process

Non-Clinical Review

Data Analysis

IND Strategy Design

Strategic Planning

Document Preparation

Dossier Assembly

IND Submission

Filing

Supplement Response

Deficiency Resolution

IND Approval

Clearance

Key Support Areas

Key Support Areas

Non-clinical data GAP analysis and additional studies

IND strategy development based on non-clinical study results

Investigator's Brochure preparation and review support

Clinical trial development strategy formulation

Clinical trial protocol development and authoring (with medical writer)

IND submission package preparation and filing strategy (with RA)

IND supplement response (non-clinical/clinical)

Differentiators

Differentiators

  • 01

    Hands-on execution support and MFDS supplement/deficiency response — strategy development beyond consultant-only engagement

  • 02

    GAP analysis of non-clinical study results from a clinical-integration perspective

  • 03

    Full-lifecycle clinical trial development planning grounded in non-clinical study outcomes

  • 04

    IND strategy designed to connect with clinical trial operations

  • 05

    Strategic development planning to achieve IND approval